To CANCER IMMUNITY Home Page

Table 1

Potential HLA-A2 binding peptides derived from the NY-BR-1 sequence.

Sequence

Designation

FLVDRKCQLDVL

p91-102

ILIDSGADI

p124-132

AVYSEILSV

p146-154

ILSVVAKLL

p151-159

KLLSHGAVI

p157-165

LLSHGAVIEV

p158-167

FLLIKNANA

p190-198

MLLQQNVDV

p223-231

LLQQNVDVFA

p224-233

IAWEKKETPV

p417-426

SLFESSAKI

p486-494

CIPESIYQKV

p497-506

KVMEINREV

p505-513

ELMDMQTFKA

p743-752

SLSKILDTV

p960-968

KILDTVHSC

p963-971

ILNEKIREEL

p1043-1052

RIQDIELKSV

p1074-1083

YLLHENCML

p1099-1107

CMLKKEIAML

p1105-1114

AMLKLEIATL

p1112-1121

KILKEKNAEL

p1137-1146

VLIAENTML

p1170-1178

CLQRKMNVDV

p1230-1239

KMNVDVSST

p1234-1242

SLDQKLFQL

p1318-1326

KLFQLQSKNM

p1322-1331

QLQSKNMWL

p1325-1333

NMWLQQQLV

p1330-1338

WLQQQLVHA

p1332-1340

KITIDIHFL

p1349-1357

YQYEKEKAET

p1385-1394

 

Copyright © 2005 by Dirk Jäger